CorMedix Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	360.32	311.71	43.47	-	0.07	0.19
Revenue Growth (YoY)	340.77%	617.03%	-	-	-65.74%	-20.19%
Cost of Revenue	13.03	-22.09	-3.03	-	0	0.15
Gross Profit	343.39	275.75	40.28	-	0.06	0.04
Selling, General & Admin	-154.69	-106.27	-58.7	35.8	20.01	16.35
Research & Development	-29.74	-19.33	-3.94	13.16	10.68	13.13
Total Operating Expenses	-184.43	-125.61	-62.64	48.96	30.69	29.48
Operating Income	193.67	150.14	-22.36	-48.96	-30.62	-29.44
Interest Income	3.28	3.85	2.58	2.68	0.33	0.01
Interest Expense	-2.77	-2.78	-0.04	-0.03	-0.03	-0.02
Other Non-Operating Income (Expense)	-9.16	-1.19	0.49	-0.03	0.04	-0.02
Total Non-Operating Income (Expense)	-8.66	-0.13	3.03	2.62	0.34	-0.02
Pretax Income	185.02	150.02	-19.33	-46.34	-30.29	-29.46
Provision for Income Taxes	-4.01	13.04	1.4	-	-0.59	-1.25
Net Income	181.01	163.06	-17.93	-46.34	-29.7	-28.21
Net Income to Common	181.01	163.06	-17.93	-46.34	-29.7	-28.21
Net Income Growth	953.61%	-	-	-	-	-
Shares Outstanding (Basic)	76	72	59	51	40	38
Shares Outstanding (Diluted)	86	80	59	51	40	38
Shares Change (YoY)	37.63%	36.41%	15.65%	26.39%	6.93%	31.87%
EPS (Basic)	2.37	2.25	-0.30	-0.91	-0.74	-0.75
EPS (Diluted)	2.13	2.04	-0.30	-0.91	-0.74	-0.75
EPS Growth	965.00%	-	-	-	-	-
Shares Outstanding	78.4	79.26	64.41	54.94	42.82	38.09
Free Cash Flow	194.71	172.79	-50.73	-38.74	-24.58	-22.58
Free Cash Flow Growth	12.69%	-	-	-	-	-
Free Cash Flow Per Share	2.26	2.15	-0.86	-0.76	-0.61	-0.60
Gross Margin	95.30%	88.46%	92.66%	-	94.29%	22.00%
Operating Margin	53.75%	48.17%	-51.43%	-	-46819.90%	-15417.50%
Profit Margin	50.24%	52.31%	-41.24%	-	-45409.90%	-14774.70%
FCF Margin	54.04%	55.43%	-116.70%	-	-37573.50%	-11826.20%
EBITDA	219	165.53	-21.9	-48.75	-30.41	-29.26
EBITDA Margin	60.78%	53.10%	-50.37%	-	-46500.30%	-15324.80%
EBIT	193.67	150.14	-22.36	-48.96	-30.62	-29.44
EBIT Margin	53.75%	48.17%	-51.43%	-	-46819.90%	-15417.50%
Effective Tax Rate	-2.16%	8.69%	-7.22%	0.00%	1.93%	4.24%

SEC Filings: 10-K · 10-Q